Nontuberculous Mycobacteria in Cystic Fibrosis

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

In this webcast from the Cystic Fibrosis Foundation, Leslie Hazel, the Director of Patient Resources for the organization, speaks to Dr. Jerry Nick from the University of Colorado about nontuberculous mycobacteria (NTM) in cystic fibrosis.

Virulent bacteria strain poses particular risk to cystic fibrosis patients, a study warns. 

The two talk about how nontuberculous mycobacteria is a group of over 100 bacteria that can settle in the lungs, becoming dangerous for CF patients. They also discuss how patients can avoid getting the disease and how it can be treated. Nick talks about how NTM is diagnosed, how frequently CF patients are tested for NTM and how the risk of contracting NTM becomes higher the older the patient is.

For cystic fibrosis patients, targeted bacterial testing could prevent premature deaths. 

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.